PTGS2 and endometrial cancer: In summary, this study provides the definitive in vivo evidence that ω-3 PUFAs strongly inhibit tumorigenesis and progression of PTEN-deficiency induced endometrial cancer through a mechanism involving reduction of COX-2 expression and PGE2 production.